FI45047C - Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi. - Google Patents

Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi.

Info

Publication number
FI45047C
FI45047C FI631219A FI121963A FI45047C FI 45047 C FI45047 C FI 45047C FI 631219 A FI631219 A FI 631219A FI 121963 A FI121963 A FI 121963A FI 45047 C FI45047 C FI 45047C
Authority
FI
Finland
Prior art keywords
sulphanilamido
methoxypyrimidine
preparation
therapeutically useful
therapeutically
Prior art date
Application number
FI631219A
Other languages
English (en)
Swedish (sv)
Other versions
FI45047B (fi
Inventor
Budesinsky Zdenek
Bydzovsky Viktor
Kopecky Jan
Prikryl Jaroslav
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Application granted granted Critical
Publication of FI45047B publication Critical patent/FI45047B/fi
Publication of FI45047C publication Critical patent/FI45047C/fi

Links

Classifications

    • HELECTRICITY
    • H02GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02MAPPARATUS FOR CONVERSION BETWEEN AC AND AC, BETWEEN AC AND DC, OR BETWEEN DC AND DC, AND FOR USE WITH MAINS OR SIMILAR POWER SUPPLY SYSTEMS; CONVERSION OF DC OR AC INPUT POWER INTO SURGE OUTPUT POWER; CONTROL OR REGULATION THEREOF
    • H02M7/00Conversion of ac power input into dc power output; Conversion of dc power input into ac power output
    • H02M7/42Conversion of dc power input into ac power output without possibility of reversal
    • H02M7/44Conversion of dc power input into ac power output without possibility of reversal by static converters
    • H02M7/48Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode
    • H02M7/53Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode using devices of a triode or transistor type requiring continuous application of a control signal
    • H02M7/537Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode using devices of a triode or transistor type requiring continuous application of a control signal using semiconductor devices only, e.g. single switched pulse inverters
    • H02M7/538Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode using devices of a triode or transistor type requiring continuous application of a control signal using semiconductor devices only, e.g. single switched pulse inverters in a push-pull configuration
    • H02M7/5381Parallel type
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines
    • HELECTRICITY
    • H02GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02MAPPARATUS FOR CONVERSION BETWEEN AC AND AC, BETWEEN AC AND DC, OR BETWEEN DC AND DC, AND FOR USE WITH MAINS OR SIMILAR POWER SUPPLY SYSTEMS; CONVERSION OF DC OR AC INPUT POWER INTO SURGE OUTPUT POWER; CONTROL OR REGULATION THEREOF
    • H02M7/00Conversion of ac power input into dc power output; Conversion of dc power input into ac power output
    • H02M7/02Conversion of ac power input into dc power output without possibility of reversal
    • H02M7/04Conversion of ac power input into dc power output without possibility of reversal by static converters
    • H02M7/06Conversion of ac power input into dc power output without possibility of reversal by static converters using discharge tubes without control electrode or semiconductor devices without control electrode
    • H02M7/068Conversion of ac power input into dc power output without possibility of reversal by static converters using discharge tubes without control electrode or semiconductor devices without control electrode mounted on a transformer
    • HELECTRICITY
    • H02GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02MAPPARATUS FOR CONVERSION BETWEEN AC AND AC, BETWEEN AC AND DC, OR BETWEEN DC AND DC, AND FOR USE WITH MAINS OR SIMILAR POWER SUPPLY SYSTEMS; CONVERSION OF DC OR AC INPUT POWER INTO SURGE OUTPUT POWER; CONTROL OR REGULATION THEREOF
    • H02M7/00Conversion of ac power input into dc power output; Conversion of dc power input into ac power output
    • H02M7/42Conversion of dc power input into ac power output without possibility of reversal
    • H02M7/44Conversion of dc power input into ac power output without possibility of reversal by static converters
    • H02M7/48Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode
    • H02M7/53Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode using devices of a triode or transistor type requiring continuous application of a control signal
    • H02M7/537Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode using devices of a triode or transistor type requiring continuous application of a control signal using semiconductor devices only, e.g. single switched pulse inverters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Power Engineering (AREA)
  • Cephalosporin Compounds (AREA)
  • Inverter Devices (AREA)
FI631219A 1962-06-15 1963-06-14 Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi. FI45047C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS368362 1962-06-15

Publications (2)

Publication Number Publication Date
FI45047B FI45047B (fi) 1971-11-30
FI45047C true FI45047C (fi) 1972-03-10

Family

ID=5377609

Family Applications (1)

Application Number Title Priority Date Filing Date
FI631219A FI45047C (fi) 1962-06-15 1963-06-14 Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi.

Country Status (10)

Country Link
US (1) US3302096A (fi)
AT (1) AT242149B (fi)
BE (1) BE633513A (fi)
CH (1) CH428742A (fi)
DK (1) DK113647B (fi)
ES (1) ES289042A1 (fi)
FI (1) FI45047C (fi)
FR (1) FR1365535A (fi)
GB (1) GB993295A (fi)
NL (2) NL294097A (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301499A (en) * 1980-06-13 1981-11-17 The United States Of America As Represented By The Secretary Of The Army Inverter circuit with current equalization

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2516563A (en) * 1948-04-19 1950-07-25 Gen Electric Magnetic amplifier for inductive loads
US2774878A (en) * 1955-08-29 1956-12-18 Honeywell Regulator Co Oscillators
US2883539A (en) * 1956-06-14 1959-04-21 Avco Mfg Corp Transverter
GB909969A (fi) * 1958-07-26

Also Published As

Publication number Publication date
NL291120A (fi) 1900-01-01
BE633513A (fi) 1900-01-01
AT242149B (de) 1965-08-25
CH428742A (de) 1967-01-31
US3302096A (en) 1967-01-31
FR1365535A (fr) 1964-07-03
DK113647B (da) 1969-04-14
GB993295A (en) 1965-05-26
FI45047B (fi) 1971-11-30
ES289042A1 (es) 1963-11-01
NL294097A (fi) 1900-01-01

Similar Documents

Publication Publication Date Title
FI42564C (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia 2-aryyliamino-1,3-diatsasykloalkeeneja
FI45970C (fi) Menetelmä terapeuttisesti arvokkaiden 1-substituoitu-2-aryyli-4- tai 5 -nitroimidatsolien valmistamiseksi.
DK104675C (da) Fremgangsmåde til fremstilling af 3-hydroxy-N-nitro-picolinamid.
SE300618B (sv) Förfarande för framställning av N-fenylpropyl- N1 -fenylpiperaziner
FI46069C (fi) Menetelmä terapeuttisesti käytettävän 1-R-2-formyyli-5-nitroimidatsoli n valmistamiseksi.
CH449670A (de) Kopierverfahren
FI46373C (fi) Menetelmä fenyyliaminopropaanin uusien terapeuttisesti käyttökelpoiste n johdannaisten valmistamiseksi.
FI41965C (fi) Menetelmä uusien terapeuttisesti vaikuttavien diaralkyyliamiinien valmistamiseksi
FI45180C (fi) Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi.
FI46507C (fi) Menetelmä uuden terapeuttisesti käytettävän 1-metyyli-N-karbobentsoksi dihydrolysergamiinin valmistamiseksi.
FI45047C (fi) Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi.
DK108015C (da) Fremgangsmåde til fremstilling af et bakteriepræparat.
CH425752A (it) Procedimento per la preparazione di cicloesilfenilchetone
DK103476C (da) Fremgangsmåde til fremstilling af 2-oxa-3-oxo-steroider.
FI43994C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 1,2-diaryyli-4-alkyyli-3,5-diokso-pyratsolidiinien valmistamiseksi
DK103512C (da) Fremgangsmåde til fremstilling af 3-nitroso-2-oxazolidon.
FI36530A (fi) Menetelmä 3-fenoksipropyyliguanidiinin valmistamiseksi
FI41400C (fi) Menetelmä uusien terapeuttisesti arvokkaiden pyrrodiliiniyhdisteiden valmistamiseksi
FI34517A (fi) 5-pyratsolyylialkamiinieetterien valmistusmenetelmä
CH419961A (de) Fertigungsstrasse
DK104063C (da) Fremgangsmåde til fremstilling af 4-hydroxy-5-halogenpyrimidiner.
IS1260A7 (is) Aðferð til framleiðslu 6-desoxy-6-desmethyltetracyclin.
FI35478A (fi) Menetelmä terapeuttisesti tehokkaan 17beta-hydroksi-17alfa-metyyli-androstaani-(3,2-c)-iso-oksatsolin valmistamiseksi
FI46729C (fi) Menetelmä uusien, terapeuttisesti käytettävien karboksiamidoalkyyli-1, 3-bentsoksatsiinien valmistamiseksi
FI46726C (fi) Menetelmä uusien terapeuttisesti käytettävien nor-3alfa- tai 3beta-tro panolin atsoniaspiraanien tai niiden estereiden valmistamiseksi.